2022
DOI: 10.2196/40567
|View full text |Cite
|
Sign up to set email alerts
|

Automatic Assessment of Intelligibility in Noise in Parkinson Disease: Validation Study

Abstract: Background Most individuals with Parkinson disease (PD) experience a degradation in their speech intelligibility. Research on the use of automatic speech recognition (ASR) to assess intelligibility is still sparse, especially when trying to replicate communication challenges in real-life conditions (ie, noisy backgrounds). Developing technologies to automatically measure intelligibility in noise can ultimately assist patients in self-managing their voice changes due to the disease. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 41 publications
0
1
0
Order By: Relevance
“…What is clear, however, is that the relentless development of sensitive and impactful analytic technologies will continue to offer new opportunities for the PD community. Already, the potential for AI approaches to personalization has been proposed [ 68 ]; the impact of new automated speech recognition technologies appears to hold great promise in detection and staging in PD [ 69 , 70 ] and the utility of chatbots such as GPT3 is already being pursued in neurodegenerative disease [ 71 ]. Interrogation of speech and acoustic signals as components of composite measures is also gaining traction, including with facial analysis [ 72 ], finger tapping [ 73 ], and nocturnal breathing events [ 74 , 75 ].…”
Section: Summary and Next Stepsmentioning
confidence: 99%
“…What is clear, however, is that the relentless development of sensitive and impactful analytic technologies will continue to offer new opportunities for the PD community. Already, the potential for AI approaches to personalization has been proposed [ 68 ]; the impact of new automated speech recognition technologies appears to hold great promise in detection and staging in PD [ 69 , 70 ] and the utility of chatbots such as GPT3 is already being pursued in neurodegenerative disease [ 71 ]. Interrogation of speech and acoustic signals as components of composite measures is also gaining traction, including with facial analysis [ 72 ], finger tapping [ 73 ], and nocturnal breathing events [ 74 , 75 ].…”
Section: Summary and Next Stepsmentioning
confidence: 99%